• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Cellectar Biosc (NQ: CLRB )

    2.100 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 2.100
    Bid (Size) 2.070 (4)
    Ask (Size) 2.280 (1)
    Prev. Close 2.100
    Today's Range 2.100 - 2.100
    52wk Range 1.820 - 4.450
    Shares Outstanding 35,848,924
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Gold Moves Higher; Coca-Cola Increases FY24 Forecast
    Via Benzinga
    Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga

    Performance

    YTD
    -26.57%
    -26.57%
    1 Month
    +7.69%
    +7.69%
    3 Month
    -30.69%
    -30.69%
    6 Month
    -48.40%
    -48.40%
    1 Year
    -14.29%
    -14.29%

    More News

    Read More
    Earnings Preview For Cellectar Biosciences
    Via Benzinga
    Recap: Cellectar Biosciences Q1 Earnings
    Via Benzinga
    Crude Oil Down 2%; GE Aerospace Earnings Top Views
    Via Benzinga
    Exposures Fossil Fuels
    Cancer-Focused Cellectar Biosciences Stock Trades Lower Despite Meeting Goal In Blood Cancer Study
    Via Benzinga
    CLRB Stock Earnings: Cellectar Biosciences Misses EPS for Q1 2024
    Via InvestorPlace
    Hedgeye Warns That Reddit (RDDT) Stock Will Fall 50%
    Via InvestorPlace
    Why Is Gamida Cell (GMDA) Stock Down 82% Today?
    Via InvestorPlace
    CLRB Stock Earnings: Cellectar Biosciences Beats EPS for Q4 2023
    Via InvestorPlace
    Earnings Scheduled For March 27, 2024
    Via Benzinga
    Cellectar Biosciences Is An 'Attractive Acquisition Target' According To This Analyst - Here's Why
    Via Benzinga
    Why Is Cancer-Focused Cellectar Biosciences Stock Trading Higher Today?
    Via Benzinga
    Wells Fargo Is Warming Up to Enphase Energy (ENPH) Stock
    Via InvestorPlace
    Why Is Spirit AeroSystems (SPR) Stock Down 14% Today?
    Via InvestorPlace
    Why Is LumiraDx (LMDX) Stock Down 13% Today?
    Via InvestorPlace
    Why Is Cellectar Biosciences (CLRB) Stock Up 16% Today?
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Via InvestorPlace
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Crude Oil Rises 1%; Verb Technology Shares Spike Higher
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Nasdaq Turns Higher; US Factory Orders Fall 2.1% In July
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Cellectar Biosciences Inc. (NASDAQ: CLRB) Near Top of Volume Charts in Tuesday Trading
    Via Investor Brand Network
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.